Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PDRN evidence and protocol review
Also known as: Polydeoxyribonucleotide
PDRN (Polydeoxyribonucleotide) is a mixture of deoxyribonucleotide fragments (commonly derived from salmon or trout sperm/testes DNA) with documented regenerative and anti-inflammatory properties across wound-healing, periodontal-regeneration, and post-procedure aesthetic-recovery applications. Its primary mechanism is selective activation of the A2A adenosine receptor and induction of the phosphate-scavenger system, overlapping with skin-regeneration processes following surgical procedures - supporting its use alongside laser resurfacing, chemical peeling, microneedling, and radiofrequency treatments. A systematic review of periodontal regeneration found significant improvements in clinical attachment level, bone fill, and probing-depth reduction versus controls; reviewers note a continued need for more RCTs with human aesthetic cohorts and longer follow-up.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
PDRN is a mixture of DNA-derived fragments, not a single peptide. The exact wound-study injections are now recorded separately; they do not validate generalized aesthetic or systemic-wellness injection schedules.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.